Fresenius Medical Care (FMS) Competitors

DaVita (NYSE:DVA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, community ranking, profitability and institutional ownership.

Is DVA or FMS more profitable?

DaVita has a net margin of 5.70% compared to DaVita's net margin of 2.56%. Fresenius Medical Care's return on equity of 64.42% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	5.70%	64.42%	4.63%
Fresenius Medical Care	2.56%	4.99%	2.15%

Do analysts prefer DVA or FMS?

DaVita currently has a consensus price target of $118.50, indicating a potential downside of 14.22%. Fresenius Medical Care has a consensus price target of $24.00, indicating a potential upside of 15.89%. Given DaVita's higher possible upside, analysts clearly believe Fresenius Medical Care is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Fresenius Medical Care	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14

Do insiders & institutionals have more ownership in DVA or FMS?

90.1% of DaVita shares are held by institutional investors. Comparatively, 8.3% of Fresenius Medical Care shares are held by institutional investors. 1.4% of DaVita shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, DVA or FMS?

DaVita has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Which has higher valuation & earnings, DVA or FMS?

DaVita has higher earnings, but lower revenue than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$12.14B	1.00	$691.53M	$7.40	18.67
Fresenius Medical Care	$21.05B	0.58	$540.07M	$0.92	22.51

Does the MarketBeat Community believe in DVA or FMS?

DaVita received 88 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.81% of users gave DaVita an outperform vote while only 53.94% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
DaVita	Outperform Votes 492 61.81%	Underperform Votes 304 38.19%
Fresenius Medical Care	Outperform Votes 404 53.94%	Underperform Votes 345 46.06%

Does the media prefer DVA or FMS?

In the previous week, DaVita had 5 more articles in the media than Fresenius Medical Care. MarketBeat recorded 8 mentions for DaVita and 3 mentions for Fresenius Medical Care. DaVita's average media sentiment score of 1.75 beat Fresenius Medical Care's score of 0.66 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

DaVita beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.